Setting a weight-loss goal might be the secret sauce for getting the most out of tirzepatide.

You know how your coach always says, "If you don't have a goal, you're just running around for no reason"? Turns out, that advice applies to weight-loss medication too.

One of the biggest real-world studies ever done on people taking tirzepatide — a medication you might know by its brand names Mounjaro or Zepbound — found that your mindset and motivation matter just as much as the medicine itself. The study was presented at ENDO 2026, the Endocrine Society's big annual meeting in Chicago.

So what did they actually find?

Scientists tracked over 80,000 adults taking tirzepatide from February 2024 through November 2025. That's a LOT of people — enough to fill a major football stadium. They wanted to figure out why some people lost a ton of weight on the medication while others barely budged.

Here's what predicted the best weight-loss results:

Being female. Women tended to lose more weight than men on tirzepatide. (Sorry, guys.)

Not already having certain health conditions. People without type 2 diabetes, high blood pressure, high cholesterol, liver disease, or sleep apnea lost more weight. More on why in a minute.

Setting a personal weight goal. This was a big one. People who actually picked a target weight — like saying "I want to lose 30 pounds" — lost significantly more weight than people who didn't set a goal.

Having tried structured diets before. If you'd already put effort into eating healthier in the past, you tended to do better on the medication.

Being self-motivated. People who lacked the internal drive to lose weight experienced minimal weight loss, even with the medication doing its thing.

In other words: the pill (well, injection) helps, but it's not magic. Your brain has to show up to the party too.

Wait — what even IS tirzepatide?

Great question. Tirzepatide is a medication that mimics two natural hormones in your body called GLP-1 and GIP. Think of these hormones as your body's built-in "I'm full, stop eating" signals. After you eat, GLP-1 tells your brain you're satisfied, slows down how fast food leaves your stomach, and helps control blood sugar. GIP does similar things and also helps your fat tissue handle nutrients better.

Most older weight-loss medications only copied one of these hormones. Tirzepatide copies both at the same time — like having two hall monitors instead of one. That's why it tends to produce more weight loss than older medications. In clinical trials, people taking the highest dose lost an average of about 20.9% of their body weight over 72 weeks. That's like a 200-pound person dropping about 42 pounds.

Tirzepatide is given as a once-a-week injection (yes, a shot — but a tiny one). It's sold as Mounjaro for treating type 2 diabetes and as Zepbound for weight management.

Why do pre-existing conditions make weight loss harder?

This is actually a well-known pattern in obesity medicine, not just with tirzepatide. People with type 2 diabetes, for example, consistently lose less weight on these medications compared to people without diabetes. Scientists think this happens because diabetes changes how your body processes energy and responds to hormones. Your metabolism is essentially playing the game on a harder difficulty setting.

The same goes for conditions like high blood pressure, high cholesterol, and sleep apnea — they're all signs that your metabolism has been struggling for a while, which can make it harder (but definitely not impossible) to lose weight.

How did the scientists figure all this out?

The researchers used some clever math tools. One is called a Cox proportional hazards model — which sounds intimidating, but here's the simple version: imagine you're timing how long it takes different runners to finish a race. This math tool lets you figure out which characteristics (like age, sex, or health conditions) make someone more likely to finish faster or slower, while accounting for the fact that not everyone finishes the race at all.

In this study, they used it to calculate how long it took people to lose 20% of their body weight. They also used another tool called multivariate mixed models, which is basically a way to look at a bunch of different factors all at once — like age, sex, health conditions, and behaviors — and figure out which ones actually matter for weight loss over 12 months.

The research team

This study was a collaboration between Voy (a digital health company based in London) and the Predictive Medicine Group at Boston Children's Hospital and Harvard Medical School. The research was led by Hans Johnson, who pointed out that this is the first study to identify both behavioral and clinical predictors of who responds best to tirzepatide.

Why should anyone care?

Because this could change how doctors prescribe and support patients on these medications. Right now, a doctor might hand you a prescription and say "good luck." But this study suggests that doctors should also be asking: Have you set a weight goal? Have you tried structured eating plans before? Do you feel motivated to lose weight?

If the answer to those questions is "not really," the research suggests that adding behavioral support — like counseling, goal-setting sessions, or structured diet programs — alongside the medication could make a real difference. Clinical trials have already shown that combining tirzepatide with intensive lifestyle programs can produce up to 25% body-weight loss, which is the largest reduction seen in any GLP-1 medication trial to date.

As Johnson put it, these findings could help doctors better counsel patients about realistic expectations and tailor their support to the needs of each patient.

The bottom line

Tirzepatide is a powerful medication, but it works best when your brain is on board too. Setting a goal, staying motivated, and pairing the medication with healthy habits aren't just nice extras — they're some of the strongest predictors of success. Think of tirzepatide as a rocket booster: it provides incredible thrust, but you still need to point the rocket in the right direction.

This article is for general education and isn't medical advice. Tirzepatide and other GLP-1 medications are powerful tools with real benefits and real risks (gastrointestinal side effects, gallbladder problems, rare pancreatitis, and others), and they should be prescribed and monitored by a clinician who knows your full medical history — not bought from online clinics that skip the evaluation. The mindset findings here are about getting the most from treatment, not pressure to lose weight: if you have a history of disordered eating, goal-setting and structured-diet advice can be a trigger rather than a help, so loop in a clinician who knows your situation before starting. The cluster's skinny-shot and weight-loss guides cover the broader medication landscape, and effective behavioral support exists for anyone who wants it.